Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Covetrus, Inc.
  6. Summary
    CVET   US22304C1009

COVETRUS, INC.

(CVET)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/13/2021 09/14/2021 09/15/2021 09/16/2021 09/17/2021 Date
20.79(c) 20.19(c) 19.67(c) 20.26(c) 20.31(c) Last
611 147 837 943 1 161 219 950 753 1 218 067 Volume
-1.61% -2.89% -2.58% +3.00% +0.25% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 4 602 M - -
Net income 2021 -38,5 M - -
Net Debt 2021 758 M - -
P/E ratio 2021 -73,4x
Yield 2021 -
Sales 2022 4 908 M - -
Net income 2022 41,6 M - -
Net Debt 2022 668 M - -
P/E ratio 2022 67,0x
Yield 2022 -
Capitalization 2 795 M 2 795 M -
EV / Sales 2021 0,77x
EV / Sales 2022 0,71x
Nbr of Employees 5 466
Free-Float 75,1%
More Financials
Company
Covetrus, Inc is a global animal-health technology and services company. The Company provides service and technology platform to animal veterinary markets. The Company operates in three segments: North America, Europe and APCA & Emerging Markets. The Company combines practice management software and supply chain distribution businesses with a technology-enabled prescription management platform and related pharmacy... 
Read more
More about the company
Ratings of Covetrus, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C
More Ratings
All news about COVETRUS, INC.
09/09VC DAILY : Digital Health Is Booming, but VC Doesn't See a Bubble Forming
DJ
08/09COVETRUS : Barclays Adjusts Price Target on Covetrus to $38 From $46, Maintains ..
MT
08/05COVETRUS : Q2 Earnings Snapshot
AQ
08/05COVETRUS : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
08/05Covetrus Seeks Acquisitions
CI
08/05COVETRUS : Earnings Flash (CVET) COVETRUS Reports Q2 Revenue $1.19B, vs. Street ..
MT
08/05COVETRUS, INC. : Results of Operations and Financial Condition, Financial Statem..
AQ
08/05COVETRUS : Announces Financial Results for Second Quarter of 2021
BU
08/05COVETRUS : Issues Inaugural Environmental, Social and Governance (ESG) Report
BU
08/05Covetrus Reports Unaudited Consolidated Earnings Results for the Second Quart..
CI
08/03COVETRUS : Announces $120K in Scholarships to Support Diversity in Veterinary Se..
BU
07/29COVETRUS : Announces Second Quarter 2021 Earnings Release Date and Conference Ca..
BU
07/23COVETRUS : Drew Coxhead brings deep accounting experience to support Covetrus' t..
PU
07/23COVETRUS, INC. : Change in Directors or Principal Officers, Financial Statements..
AQ
07/22COVETRUS : Names New Chief Accounting Officer
MT
More news
News in other languages on COVETRUS, INC.
06/28COVETRUS : introduit de nouveaux postes et une nouvelle direction dans ses activ..
06/28COVETRUS : besetzt neue Rollen und Führungspositionen in seinen nordamerikanisch..
06/28COVETRUS : presenta nuevas funciones y cargos directivos en sus negocios de Nort..
03/08COVETRUS : anuncia al vicepresidente de la Gestión de Talentos a nivel Global
03/08COVETRUS : beruft Vice President of Global Talent Management
More news
Analyst Recommendations on COVETRUS, INC.
More recommendations
Stock Trading Strategies
COVETRUS, INC. - 2020
The stock is approaching a major resistance level
BUY
More Stock Trading Analysis
Chart COVETRUS, INC.
Duration : Period :
Covetrus, Inc. Technical Analysis Chart | CVET | US22304C1009 | MarketScreener
Technical analysis trends COVETRUS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Last Close Price 20,31 $
Average target price 30,83 $
Spread / Average Target 51,8%
EPS Revisions
Managers and Directors
Benjamin C. Wolin President, Chief Executive Officer & Director
Matthew J. Foulston Chief Financial Officer & Executive Vice President
Philip A. Laskaway Chairman
Georgina Wraight President-Global Technology Solutions & EVP
Steve Palmucci Global Chief Information Officer
Sector and Competitors
1st jan.Capi. (M$)
COVETRUS, INC.-29.33%2 795
ABBOTT LABORATORIES15.80%224 776
MEDTRONIC PLC10.72%174 552
BECTON, DICKINSON AND COMPANY4.69%75 229
HOYA CORPORATION30.10%62 323
ALIGN TECHNOLOGY, INC.34.62%56 839